104 related articles for article (PubMed ID: 15126538)
21. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
22. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
[TBL] [Abstract][Full Text] [Related]
23. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
[TBL] [Abstract][Full Text] [Related]
24. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy.
Yarasheski KE; Tebas P; Stanerson B; Claxton S; Marin D; Bae K; Kennedy M; Tantisiriwat W; Powderly WG
J Appl Physiol (1985); 2001 Jan; 90(1):133-8. PubMed ID: 11133903
[TBL] [Abstract][Full Text] [Related]
25. Muscle adiposity and body fat distribution in type 1 and type 2 diabetes: varying relationships according to diabetes type.
Dubé MC; Joanisse DR; Prud'homme D; Lemieux S; Bouchard C; Pérusse L; Lavoie C; Weisnagel SJ
Int J Obes (Lond); 2006 Dec; 30(12):1721-8. PubMed ID: 16652137
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
27. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
[TBL] [Abstract][Full Text] [Related]
29. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy.
Yanovski JA; Miller KD; Kino T; Friedman TC; Chrousos GP; Tsigos C; Falloon J
J Clin Endocrinol Metab; 1999 Jun; 84(6):1925-31. PubMed ID: 10372688
[TBL] [Abstract][Full Text] [Related]
30. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic therapy for HIV-associated lipodystrophy.
Benavides S; Nahata MC
Ann Pharmacother; 2004 Mar; 38(3):448-57. PubMed ID: 14755064
[TBL] [Abstract][Full Text] [Related]
32. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
[TBL] [Abstract][Full Text] [Related]
33. Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy.
Saint-Marc T; Touraine JL
AIDS; 1999 May; 13(8):1000-2. PubMed ID: 10371188
[No Abstract] [Full Text] [Related]
34. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.
Lindegaard B; Hansen T; Hvid T; van Hall G; Plomgaard P; Ditlevsen S; Gerstoft J; Pedersen BK
J Clin Endocrinol Metab; 2008 Oct; 93(10):3860-9. PubMed ID: 18628529
[TBL] [Abstract][Full Text] [Related]
35. Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
Coll B; van Wijk JP; Parra S; Castro Cabezas M; Hoepelman IM; Alonso-Villaverde C; de Koning EJ; Camps J; Ferre N; Rabelink TJ; Tous M; Joven J
Eur J Pharmacol; 2006 Aug; 544(1-3):104-10. PubMed ID: 16843455
[TBL] [Abstract][Full Text] [Related]
36. Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study.
Robinson FP; Quinn LT; Rimmer JH
Biol Res Nurs; 2007 Jan; 8(3):177-85. PubMed ID: 17172316
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
38. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.
Hirsch L; Byron K; Gibney M
Diabetes Technol Ther; 2014 Dec; 16(12):867-73. PubMed ID: 25329935
[TBL] [Abstract][Full Text] [Related]
39. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.
Tien PC; Benson C; Zolopa AR; Sidney S; Osmond D; Grunfeld C
Am J Epidemiol; 2006 May; 163(9):860-9. PubMed ID: 16524955
[TBL] [Abstract][Full Text] [Related]
40. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
